Trofosfamide in the Palliative Treatment of Cancer: A Review of the Literature
作者： D. Latz , N. Nassar , R. Frank
DOI: 10.1159/000081342
关键词: Oncology 、 MEDLINE 、 Trofosfamide 、 Cancer 、 Treatment outcome 、 Internal medicine 、 Broad spectrum 、 Palliative treatment 、 Medicine
摘要: Trofosfamide is an alkylating agent that derived from the oxazaphoshorines. It has found application in a broad spectrum of malignancies the last three decades. The main indications for appli
karger.com
sci-hub.se 参考文章(35)
Alexander H. Enk, Jürgen Knop, Verlaufsstabilisierung von Patienten mit fortgeschrittenen malignen Melanomen in Stadium IV durch Trofosfamidbehandlung Hautarzt. ,vol. 51, pp. 486- 489 ,(2000) , 10.1007/S001050051158
P.O. Andersson, I. Braide, H. Nilsson-Ehle, Trofosfamide as salvage therapy for anaplastic large cell lymphoma relapsing after high-dose chemotherapy. Leukemia & Lymphoma. ,vol. 43, pp. 2351- 2353 ,(2002) , 10.1080/1042819021000040053
Jan Norum, Complete remission after repeated trofosfamide treatment in relapsing high-grade malignant non-Hodgkin's lymphoma--a case report. Acta Oncologica. ,vol. 33, pp. 831- 831 ,(1994) , 10.3109/02841869409083956
Dirk Strumberg, Andreas Harstrick, Ute Klaassen, Christian M??ller, Wilfried Eberhardt, Michael W Korn, Hansjochen Wilke, Siegfried Seeber, Phase II trial of continuous oral trofosfamide in patients with advanced colorectal cancer refractory to 5-fluorouracil. Anti-Cancer Drugs. ,vol. 8, pp. 293- 295 ,(1997) , 10.1097/00001813-199703000-00012
G.J. Wiedemann, R. Zschaber, S. Hegewisch-Becker, P. Reichardt, K. Weber, D. Uthgenannt, O. Löwenstrom, E. Jäger, M. Freund, R. Seeger, A.C. Feller, H. Merz, J.H. Hartlapp, T. Wagner, H.J. Illiger, Two Oral Trofosfamide Schedules in Elderly Patients with Refractory Non-Hodgkin‘s Lymphoma Onkologie. ,vol. 22, pp. 134- 138 ,(1999) , 10.1159/000026942
Johannes E. A. Wolff, Gabriele M�lenkamp, Silke Westphal, Thorsten Pietsch, Astrid Gnekow, Rolf-Dieter Kortmann, Joachim Kuehl, Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme. Cancer. ,vol. 89, pp. 2131- 2137 ,(2000) , 10.1002/1097-0142(20001115)89:10<2131::AID-CNCR14>3.0.CO;2-J
E.-S. Strobel, E. Fritschka, Hereditary Premenopausal Breast Cancer Onkologie. ,vol. 25, pp. 24- 27 ,(2002) , 10.1159/000055198
E. Wist, T. Risberg, Trofosfamide in non-Hodgkin's lymphoma. A phase II study. Acta Oncologica. ,vol. 30, pp. 819- 821 ,(1991) , 10.3109/02841869109091828
P. Reichardt, D. Pink, J. Tilgner, A. Kretzschmar, P.C. Thuss-Patience, B. Dörken, Oral Trofosfamide: An Active and Well-Tolerated Maintenance Therapy for Adult Patients with Advanced Bone and Soft Tissue Sarcomas. Results of a Retrospective Analysis Onkologie. ,vol. 25, pp. 541- 546 ,(2002) , 10.1159/000068625
T. Gierlich, C. Unger, K. Mross, A. Rüther, Tumor Growth Control by Oral Trofosfamide in Patients with Metastatic Breast Cancer Onkologie. ,vol. 21, pp. 52- 56 ,(1998) , 10.1159/000026777